Evaluation of Short-Term Side Effects Following the First Dose of COVID-19 Vaccines Among Physicians and Dentists: A Cross-Sectional Study from India

Majumder, Md Anwarul Azim ORCID logoORCID: https://orcid.org/0000-0003-3398-8695, Singh, Keerti ORCID logoORCID: https://orcid.org/0000-0001-7532-1229, Johnson, WMS, Rajasundaram, Archana, Gupta, Subir, Gaur, Uma, Kumar, Santosh ORCID logoORCID: https://orcid.org/0000-0002-5117-7872, Chatterjee, Madhuri, Fazle Rabbi, Ahbab Mohammad ORCID logoORCID: https://orcid.org/0000-0001-8627-187X, Sangishetti, Vijay Prasad, Rahman, Sayeeda ORCID logoORCID: https://orcid.org/0000-0002-7005-8801, Campbell, Michael H ORCID logoORCID: https://orcid.org/0000-0002-5927-2612, Harewood, Heather ORCID logoORCID: https://orcid.org/0000-0002-4114-2342, Bharatha, Ambadasu ORCID logoORCID: https://orcid.org/0000-0003-0287-3959, Krishnamurthy, Kandamaran ORCID logoORCID: https://orcid.org/0000-0001-5592-7020, Kabir, Russell ORCID logoORCID: https://orcid.org/0000-0001-9257-2775, Parsa, Ali Davod ORCID logoORCID: https://orcid.org/0000-0001-7390-4308, Mohammmad, Shegufta ORCID logoORCID: https://orcid.org/0000-0001-9567-6289, Haque, Mainul ORCID logoORCID: https://orcid.org/0000-0002-6124-7993 and Razzaque, Mohammed S (2023) Evaluation of Short-Term Side Effects Following the First Dose of COVID-19 Vaccines Among Physicians and Dentists: A Cross-Sectional Study from India. Journal of Multidisciplinary Healthcare, 16. pp. 161-174. ISSN 1178-2390

Published Version
Available under the following license: Creative Commons Attribution Non-commercial.

Download (701kB) | Preview
Official URL: http://dx.doi.org/10.2147/jmdh.s390364


Background: Efficacy and safety are fundamental for the development of successful COVID-19 vaccines. Vaccine-associated side effects influence vaccine hesitancy. This study investigated the prevalence, severity, and onset of side effects following the first dose of COVID-19 vaccines among physicians and dentists working in various healthcare settings across India. Methods: A cross-sectional survey collected self-report data from April to June 2021 on side effects following the first dose of the vaccine. An online validated questionnaire using the Google Docs® platform was circulated via email and social media platforms. Results: More than 40% of participants experienced at least one side effect after the first dose of vaccination; the most common were mild and resolved within three days after vaccination. More than 91% of respondents received the Covishield (AstraZeneca) vaccine; the most prevalent adverse effects were soreness of the injected arm (78.9%), tiredness (71.1%), and fever (54.9%). Logistic regression showed that women were almost 60% less likely to report side effects. Conclusion: Findings supported the safety of the first dose of the COVID-19 vaccine based on relatively few self-limiting side effects, mainly soreness of the injected arm and tiredness. Further research is needed to determine the long-term safety of COVID-19 vaccines, especially after booster doses.

Item Type: Journal Article
Keywords: prevalence, adverse effects, COVID-19 vaccine, physicians, dentists, India
Faculty: COVID-19 Research Collection
Faculty of Health, Education, Medicine & Social Care
SWORD Depositor: Symplectic User
Depositing User: Symplectic User
Date Deposited: 27 Jan 2023 16:10
Last Modified: 27 Jan 2023 16:10
URI: https://arro.anglia.ac.uk/id/eprint/708218

Actions (login required)

Edit Item Edit Item